Anavex Life Sciences Corp (AVXL)

[Lima4918]

So let me get this straight.

Anavex market cap was $274M yesterday afternoon before the news, and given the premarket price action the market is valuing the news today at $21M or an increase of 8% from yesterdays close.

So, $21M is the value of Anavex having the right to sell its drug in Australia on a person by person basis (pre-approval).

Just IMO, that is breathtaking. Proof of an inefficient market IMO.

Am I missing something here?


Remember when the stock ran to $15 or $18 based on the hope of an Alz treatment even though the company was not conducting (at the time) a placebo controlled registered clinical study? Now we are 50% enrolled in ALZ and the green light to sell and make money in Aus and that's worth $21M?

Also, don't you think the TGA has all of the information from ANAVEX regarding the trial participants in the OLE study? I am sure that affected their decision to grant this permission to Anavex. I am not talking about blinded data, but the OLE data.

Edit: The market just opened and the value is now $10M. WOW